Previous 10 | Next 10 |
RICHMOND HILL, Ontario, Oct. 25, 2019 (GLOBE NEWSWIRE) -- Helix BioPharma Corp. (TSX: “HBP”), an immuno-oncology company developing drug candidates for the prevention and treatment of cancer, today announced its financial results for the year ended July 31, 2019. FINANCIAL...
ST. LOUIS, Oct. 16, 2019 (GLOBE NEWSWIRE) -- Huttig Building Products (Nasdaq: HBP), one of the nation's largest wholesale distributors of millwork and specialty building products used principally in new residential construction and home improvement, plans to release its third quarter 2019 ...
CHICAGO, Oct. 01, 2019 (GLOBE NEWSWIRE) -- AZEK Building Products and Huttig Building Products (Nasdaq: HBP) have announced a new partnership intended to service key areas in the Washington and Oregon markets. Huttig Building Products, one of the nation’s largest wholesale distributo...
RICHMOND HILL, Ontario, Sept. 03, 2019 (GLOBE NEWSWIRE) -- Helix BioPharma Corp. (TSX: HBP), (“Helix” or the “Company”), an immuno-oncology company developing innovative drug candidates for the prevention and treatment of cancer, is pleased to announce that they,...
RICHMOND HILL, Ontario, Aug. 21, 2019 (GLOBE NEWSWIRE) -- Helix BioPharma Corp. (TSX: “HBP”) (“Helix” or the “Company”), an immuno-oncology company developing innovative drug candidates for the prevention and treatment of cancer, today announced it ...
RICHMOND HILL, Ontario, Aug. 07, 2019 (GLOBE NEWSWIRE) -- Helix BioPharma Corp. (TSX: HBP), (“Helix” or the “Company”), an immuno-oncology company developing innovative drug candidates for the prevention and treatment of cancer, announced that it has received app...
Huttig Building Products, Inc. (HBP) Q2 2019 Results Conference Call July 30, 2019 11:00 AM ET Company Participants Philip Keipp - Vice President and Chief Financial Officer Jon Vrabely - President and Chief Executive Officer Bob Furio - Executive Vice President and Chief Operati...
Huttig Building Products (NASDAQ: HBP ): Q2 GAAP EPS of -$0.40. More news on: Huttig Building Products, Inc., Earnings news and commentary, , Read more ...
Second Quarter 2019 Highlights: Net sales of $218.5 million Operating income increased 57% to $3.3 million Operating cash needs reduced by $15.6 million Successfully completed a major enterprise resource planning system upgrade ST. LOUIS, July 29, 2019 (GLOBE NEWSWIRE...
RICHMOND HILL, Ontario, July 24, 2019 (GLOBE NEWSWIRE) -- Helix BioPharma Corp. (TSX: HBP), (“Helix” or the “Company”), an immuno-oncology company developing innovative drug candidates for the prevention and treatment of cancer, announces that it will be presenti...
News, Short Squeeze, Breakout and More Instantly...
Huttig Building Products Inc. Company Name:
HBP Stock Symbol:
NASDAQ Market:
Huttig Building Products Inc. Website:
--News Direct-- Toronto, Ontario – TheNewswire – December 14, 2023 – Helix BioPharma Corp. (TSX:HBP), (“Helix” or the “Company”), a clinical-stage biopharmaceutical company developing unique therapies in the field of immuno-oncology based o...
(TheNewswire) Toronto, Ontario - TheNewswire - October 27, 2023 - Helix BioPharma Corp. (TSX:HBP) , (“ Helix ” or the “ Company ”), a clinical-stage biopharmaceutical company developing unique therapies in the field of immu...
--News Direct-- Toronto, Ontario - TheNewswire - October 10, 2023 - Helix BioPharma Corp. (TSX:HBP) (“Helix” or the “Company”), an immune-oncology antibody-drug-conjugate company developing an innovative drug platform for the treatment of cancer, announced today th...